Form DEF 14C - Other definitive information statements:
SEC Accession No. 0001683168-22-000298
Filing Date
2022-01-18
Accepted
2022-01-18 15:56:51
Documents
1
Period of Report
2022-01-20

Document Format Files

Seq Description Document Type Size
1 DEF 14C sunshine_def14c.htm DEF 14C 117061
  Complete submission text file 0001683168-22-000298.txt   118361
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: DEF 14C | Act: 34 | File No.: 000-52898 | Film No.: 22535132
SIC: 8731 Services-Commercial Physical & Biological Research